Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4231 AL 4245

[Role of Mediterranean diet on the prevention of Alzheimer disease]

Miranda A, Gómez-Gaete C, Mennickent S.

Rev Med Chil. 2017 Apr;145(4):501-507. doi: 10.4067/S0034-98872017000400010.

[Efficacy and tolerance of Memantine monotherapy and combination therapy with Reinhartdt And Sea Cucumber Capsule on agitation in moderate to severe Alzheimer disease]

Yu EY, Liao ZL, Tan YF, Qiu YJ, Zhu JP, Chen Y, Lin SS, Wu MH.

Zhonghua Yi Xue Za Zhi. 2017 Jul 18;97(27):2091-2094. doi: 10.3760/cma.j.issn.0376-2491.2017.27.003.

Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease

Prickaerts J, Heckman PRA, Blokland A.

Expert Opin Investig Drugs. 2017 Sep;26(9):1033-1048. doi: 10.1080/13543784.2017.1364360. Epub 2017 Aug 9.

Phosphodiesterase-4B as a Therapeutic Target for Cognitive Impairment and Obesity-Related Metabolic Diseases

Clapcote SJ.

Adv Neurobiol. 2017;17:103-131. doi: 10.1007/978-3-319-58811-7_5.

Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: A systematic review and meta-analysis

Araya-Quintanilla F, Gutiérrez-Espinoza H, Sánchez-Montoya U, Muñoz-Yañez MJ, Baeza-Vergara A, Petersen-Yanjarí M, Fernández-Lecaros L.

Neurologia (Engl Ed). 2020 Mar;35(2):105-114. doi: 10.1016/j.nrl.2017.07.009. Epub 2017 Oct 4.

Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer's disease

Liu CS, Rau A, Gallagher D, Rajji TK, Lanctôt KL, Herrmann N.

Neurodegener Dis Manag. 2017 Oct;7(5):317-329. doi: 10.2217/nmt-2017-0021. Epub 2017 Oct 18.

Cognitive telerehabilitation in mild cognitive impairment, Alzheimer's disease and frontotemporal dementia: A systematic review

Cotelli M, Manenti R, Brambilla M, Gobbi E, Ferrari C, Binetti G, Cappa SF.

J Telemed Telecare. 2019 Feb;25(2):67-79. doi: 10.1177/1357633X17740390. Epub 2017 Nov 8.

Revalidation of the neuroprotective effects of a United States patented polyherbal formulation on scopolamine induced learning and memory impairment in rats

Upadhyay P, Sadhu A, Singh PK, Agrawal A, Ilango K, Purohit S, Dubey GP.

Biomed Pharmacother. 2018 Jan;97:1046-1052. doi: 10.1016/j.biopha.2017.11.008. Epub 2017 Nov 9.

Resveratrol, pterostilbene, and dementia

Lange KW, Li S.

Biofactors. 2018 Jan;44(1):83-90. doi: 10.1002/biof.1396. Epub 2017 Nov 23.

Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review

Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, Ratner E, Calvert C, Barclay TR, Brasure M, Nelson VA, Kane RL.

Ann Intern Med. 2018 Jan 2;168(1):39-51. doi: 10.7326/M17-1529. Epub 2017 Dec 19.

Understanding and Supporting Persons With Memory Loss and Their Families Across the Spectrum of Dementia

Gaugler JE.

J Appl Gerontol. 2017 Jul;36(7):779-781. doi: 10.1177/0733464817710755.

Alzheimer disease in 2016: Putting AD treatments and biomarkers to the test

Reiman EM.

Nat Rev Neurol. 2017 Feb;13(2):74-76. doi: 10.1038/nrneurol.2017.1. Epub 2017 Jan 13.

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease

Muszyński P, Groblewska M, Kulczyńska-Przybik A, Kułakowska A, Mroczko B.

Curr Neuropharmacol. 2017;15(6):906-917. doi: 10.2174/1570159X15666170208124324.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias